Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
October 13, 2023 at 17:47 PM EDT
Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected.
